Screening tests for aphasia in patients with stroke: a systematic review

• Published in: Journal of Neurology Vol. 264; no. 2; pp. 211 - 220
• Main Authors: El Hachioui, Hanane, Visch-Brink, Evy G., de Lau, Lonneke M. L., van de Sandt-Koenderman, Mieke W. M. E., Nouwens, Femke, Koudstaal, Peter J., Dippel, Diederik W. J.
• Format: Journal Article Book Review
• Language: English
• Published: Berlin/Heidelberg Springer Berlin Heidelberg 01.02.2017; Springer Nature B.V
• Subjects: Aphasia - diagnosis; Aphasia - etiology; Humans; Medicine; Medicine & Public Health; Neurology; Neuroradiology; Neurosciences; Review; Stroke - complications; Stroke - diagnosis; Aphasia; Infarction; Screening test; Cerebrovascular disease/stroke; Intracerebral hemorrhage; Diagnostic test assessment
• ISSN: 0340-5354; 1432-1459
• DOI: 10.1007/s00415-016-8170-8

Aphasia has a large impact on the quality of life and adds significantly to the costs of stroke care. Early recognition of aphasia in stroke patients is important for prognostication and well-timed treatment planning. We aimed to identify available screening tests for differentiating between aphasic and non-aphasic stroke patients, and to evaluate test accuracy, reliability, and feasibility. We searched PubMed, EMbase, Web of Science, and PsycINFO for published studies on screening tests aimed at assessing aphasia in stroke patients. The reference lists of the selected articles were scanned, and several experts were contacted to detect additional references. Of each screening test, we estimated the sensitivity, specificity, likelihood ratio of a positive test, likelihood ratio of a negative test, and diagnostic odds ratio (DOR), and rated the degree of bias of the validation method. We included ten studies evaluating eight screening tests. There was a large variation across studies regarding sample size, patient characteristics, and reference tests used for validation. Many papers failed to report on the consecutiveness of patient inclusion, time between aphasia onset and administration of the screening test, and blinding. Of the three studies that were rated as having an intermediate or low risk of bias, the DOR was highest for the Language Screening Test and ScreeLing. Several screening tools for aphasia in stroke are available, but many tests have not been verified properly. Methodologically sound validation studies of aphasia screening tests are needed to determine their usefulness in clinical practice.